These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 27170339)
1. Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency. Sultana T; DeVita MV; Michelis MF Int Urol Nephrol; 2016 Sep; 48(9):1519-24. PubMed ID: 27170339 [TBL] [Abstract][Full Text] [Related]
2. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Attallah N; Osman-Malik Y; Frinak S; Besarab A Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942 [TBL] [Abstract][Full Text] [Related]
3. Effect of an intravenous iron dextran regimen on iron stores, hemoglobin, and erythropoietin requirements in hemodialysis patients. Park L; Uhthoff T; Tierney M; Nadler S Am J Kidney Dis; 1998 May; 31(5):835-40. PubMed ID: 9590194 [TBL] [Abstract][Full Text] [Related]
4. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. Tarng DC; Wei YH; Huang TP; Kuo BI; Yang WC Kidney Int; 1999 Jun; 55(6):2477-86. PubMed ID: 10354297 [TBL] [Abstract][Full Text] [Related]
5. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178 [TBL] [Abstract][Full Text] [Related]
6. Oral use of iron with vitamin C in hemodialyzed patients. Mydlík M; Derzsiová K; Boldizsár J; Hríbiková M; Petrovicová J J Ren Nutr; 2003 Jan; 13(1):47-51. PubMed ID: 12563623 [TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hyperferritinemia. Shahrbanoo K; Taziki O Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):933-6. PubMed ID: 18974579 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a low monthly dose of intravenous iron sucrose in peritoneal dialysis patients. Mitsopoulos E; Lysitska A; Pateinakis P; Lamprou V; Intzevidou E; Minasidis I; Katsaounou C; Kougioumtzidou O; Anagnostou N; Lemonidis N; Papadopoulou D Int Urol Nephrol; 2020 Feb; 52(2):387-392. PubMed ID: 31894555 [TBL] [Abstract][Full Text] [Related]
9. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis. Kobayashi H; Abe M; Okada K; Tei R; Maruyama N; Kikuchi F; Higuchi T; Soma M Nutrients; 2015 May; 7(5):3783-95. PubMed ID: 25988769 [TBL] [Abstract][Full Text] [Related]
10. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438 [TBL] [Abstract][Full Text] [Related]
11. Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients. Keven K; Kutlay S; Nergizoglu G; Ertürk S Am J Kidney Dis; 2003 Jun; 41(6):1233-9. PubMed ID: 12776276 [TBL] [Abstract][Full Text] [Related]
12. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis. Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416 [TBL] [Abstract][Full Text] [Related]
13. Red cell ferritin, a marker of iron deficiency in hemodialysis patients. Bhandari S; Owda AK; Kendall RG; Moran N; Norfolk DR; Brownjohn AM; Turney JH Ren Fail; 1997 Nov; 19(6):771-80. PubMed ID: 9415934 [TBL] [Abstract][Full Text] [Related]
14. Vitamin A supplementation in children with poor vitamin A and iron status increases erythropoietin and hemoglobin concentrations without changing total body iron. Zimmermann MB; Biebinger R; Rohner F; Dib A; Zeder C; Hurrell RF; Chaouki N Am J Clin Nutr; 2006 Sep; 84(3):580-6. PubMed ID: 16960172 [TBL] [Abstract][Full Text] [Related]
15. Beneficial hematologic effects of daily oral ascorbic acid therapy in ESRD patients with anemia and abnormal iron homeostasis: a preliminary study. Sirover WD; Siddiqui AA; Benz RL Ren Fail; 2008; 30(9):884-9. PubMed ID: 18925528 [TBL] [Abstract][Full Text] [Related]
16. Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patients. Agarwal G; Hirachan P; Gelfond J; Fanti P; Hura C; Bansal S BMC Nephrol; 2016 Oct; 17(1):144. PubMed ID: 27717322 [TBL] [Abstract][Full Text] [Related]
17. Low dose intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in diabetic hemodialysis patients with iron overload. Lin CL; Hsu PY; Yang HY; Huang CC Ren Fail; 2003 May; 25(3):445-53. PubMed ID: 12803508 [TBL] [Abstract][Full Text] [Related]
18. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial. Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761 [TBL] [Abstract][Full Text] [Related]
19. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. Li H; Wang SX Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498 [TBL] [Abstract][Full Text] [Related]
20. Functional iron deficiency in hemodialysis patients with high ferritin. Kopelman RC; Smith L; Peoples L; Biesecker R; Rizkala AR Hemodial Int; 2007 Apr; 11(2):238-46. PubMed ID: 17403177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]